| 产品详情 |
| Edit |   |
|---|
| Product Name | MAP3K8/Tpl2/COT Peptide |
|---|
| Description | Synthetic peptides corresponding to unique epitope on MAP3K8. The peptide sequence was selected from C-terminal-region, amimo acids 365-467. This peptide was covalently modified post-synthetically to achieve desired antigenicity. |
|---|
| Size | 0.25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | Antibody Competition |
|---|
| Other Names | Cancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2 |
|---|
| Gene, Accession, CAS # | MAP3K8, Gene ID: 1326, SwissProt: AAI13567 |
|---|
| Catalog # | NBP1-49679PEP |
|---|
| Price | |
|---|
| Order / More Info | MAP3K8/Tpl2/COT Peptide from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|